These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9783762)

  • 1. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus.
    Gonzalez-Crespo MR; Navarro JA; Arenas J; Martin-Mola E; De La Cruz J; Gomez-Reino JJ
    Br J Rheumatol; 1998 Sep; 37(9):972-7. PubMed ID: 9783762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum measures of nitric oxide production with lupus disease activity.
    Gilkeson G; Cannon C; Oates J; Reilly C; Goldman D; Petri M
    J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.
    Oates JC; Shaftman SR; Self SE; Gilkeson GS
    Arthritis Rheum; 2008 Jan; 58(1):263-72. PubMed ID: 18163495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak DV; Kuznetsova TV; Kobylianskiĭ AG; Kliukvina NG; Reshetniak TM; Nasonov EL
    Ter Arkh; 2004; 76(5):19-22. PubMed ID: 15230126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary mononuclear cell and disease activity of systemic lupus erythematosus.
    Chan RW; Lai FM; Li EK; Tam LS; Chung KY; Chow KM; Li PK; Szeto CC
    Lupus; 2006; 15(5):262-7. PubMed ID: 16761499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity.
    Oates JC; Christensen EF; Reilly CM; Self SE; Gilkeson GS
    Proc Assoc Am Physicians; 1999; 111(6):611-21. PubMed ID: 10591091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
    Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
    Elewa EA; El Tokhy MA; Fathy SE; Talaat AM
    Lupus; 2015 Feb; 24(2):138-46. PubMed ID: 25199807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY; Kim SK
    Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urinary interleukin-6 in systemic lupus erythematosus.
    Peterson E; Robertson AD; Emlen W
    Lupus; 1996 Dec; 5(6):571-5. PubMed ID: 9116699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC; Harmon ME; Burlingame R; Du Clos TW
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
    Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
    Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
    Wu Q; Yang Q; Sun H
    Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
    Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
    Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.